GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Oct 2020 03:30 PM
RNS
Director/PDMR Shareholding
14 Oct 2020 03:29 PM
RNS
Director/PDMR Shareholding
13 Oct 2020 02:41 PM
RNS
Director/PDMR Shareholding
13 Oct 2020 02:08 PM
RNS
Director/PDMR Shareholding
13 Oct 2020 02:01 PM
RNS
Director/PDMR Shareholding
13 Oct 2020 01:55 PM
RNS
Director/PDMR Shareholding
13 Oct 2020 01:49 PM
RNS
Director/PDMR Shareholding
01 Oct 2020 04:30 PM
RNS
Total Voting Rights
22 Sep 2020 05:42 PM
RNS
Sanofi/GSK agree up to 72m Canada COVID doses
11 Sep 2020 03:17 PM
RNS
Director/PDMR Shareholding
10 Sep 2020 10:01 AM
RNS
Director/PDMR Shareholding
09 Sep 2020 03:11 PM
RNS
Director/PDMR Shareholding
09 Sep 2020 12:47 PM
RNS
Director/PDMR Shareholding
03 Sep 2020 07:00 AM
RNS
Sanofi/GSK: Phase 1/2 trial of COVID-19 vaccine
01 Sep 2020 03:23 PM
RNS
Total Voting Rights
13 Aug 2020 10:48 AM
RNS
Director/PDMR Shareholding
06 Aug 2020 07:00 AM
RNS
US FDA approves GSK's BLENREP for multiple myeloma
03 Aug 2020 11:31 AM
RNS
Total Voting Rights
03 Aug 2020 07:00 AM
RNS
Sanofi/GSK to supply EU with 300m COVID 19 doses
31 Jul 2020 12:00 PM
RNS
Sanofi & GSK picked for Op. Warp Speed by US Gov.
29 Jul 2020 02:02 PM
RNS
Director/PDMR Shareholding
29 Jul 2020 12:00 PM
RNS
2nd Quarter Results
29 Jul 2020 07:00 AM
RNS
Sanofi and GSK agree UK doses of COVID-19 vaccine
28 Jul 2020 03:23 PM
RNS
Director/PDMR Shareholding
24 Jul 2020 01:16 PM
RNS
GSK receives positive CHMP opinion for Belamaf
20 Jul 2020 07:00 AM
RNS
GSK and CureVac enter collaboration
15 Jul 2020 09:31 AM
RNS
Director/PDMR Shareholding
15 Jul 2020 07:00 AM
RNS
FDA Panel Votes IN FAVOR of Belantamab mafodotin
14 Jul 2020 01:19 PM
RNS
Director/PDMR Shareholding
13 Jul 2020 05:42 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 04:41 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 03:15 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 03:07 PM
RNS
Director/PDMR Shareholding
01 Jul 2020 12:25 PM
RNS
Total Voting Rights
29 Jun 2020 08:00 AM
RNS
GSK's daprodustat gains first regulatory approval
19 Jun 2020 03:22 PM
RNS
FDA Advisory Committee review belantamab mafodotin
18 Jun 2020 12:25 PM
RNS
Director/PDMR Shareholding
16 Jun 2020 12:51 PM
RNS
Director/PDMR Shareholding
11 Jun 2020 03:56 PM
RNS
Director/PDMR Shareholding
09 Jun 2020 02:16 PM
RNS
Director/PDMR Shareholding
01 Jun 2020 12:14 PM
RNS
Total Voting Rights
29 May 2020 04:41 PM
RNS
Second Price Monitoring Extn
29 May 2020 04:37 PM
RNS
Price Monitoring Extension
26 May 2020 11:53 AM
RNS
Block listing Interim Review
19 May 2020 05:51 PM
RNS
Holding(s) in Company
18 May 2020 07:09 AM
RNS
ViiV PrEP jab shows high efficacy over daily pill
13 May 2020 05:04 PM
RNS
Director/PDMR Shareholding
11 May 2020 06:07 PM
RNS
Director/PDMR Shareholding
07 May 2020 03:52 PM
RNS
Director/PDMR Shareholding
07 May 2020 07:56 AM
RNS
GSK sells its holding in Hindustan Unilever

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings